Share on LinkedInShare on LinkedIn

ARTICLE · 30 JUNE 2021

Market Intelligence Thought Leadership Award Winner

A New Sector For Price Squeeze Analysis: Medical Device Secondary Markets

ELIG Gürkaynak Attorneys-at-Law
ELIG Gürkaynak Attorneys-at-Law
Contributor
ELIG Gürkaynak Attorneys-at-Law

ELIG Gürkaynak Attorneys-at-Law

ELIG Gürkaynak Attorneys-at-Law is an eminent, independent Turkish law firm based in Istanbul. The...

View firm profile
Explore more from ELIG Gürkaynak Attorneys-at-Law

Turkish competition law addresses the issue of "price squeeze" (or margin squeeze) under Article 6 of the Law No. 4054 on the Protection of Competition ("Law No. 4054") which prohibits the abuse of dominant position.

TurkeyAntitrust/Competition Law
  1. Introduction

Turkish competition law addresses the issue of "price squeeze" (or margin squeeze) under Article 6 of the Law No. 4054 on the Protection of Competition ("Law No. 4054") which prohibits the abuse of dominant position. So far, the Turkish Competition Board ("Board") has assessed only a very limited number of cases that dealt with the price squeeze.

The Board`s SIEMENS decision1 published in March 2021 was an unexpected contribution to the Board's limited precedents on price squeeze. The decision is important mainly for two reasons. First, SIEMENS is the Board's first decision dealing with the price squeeze in the medical devices sector. Secondly, although the Board had previously looked into very similar allegations in the medical devices sector, it had never considered that the allegations might constitute a violation stemming from the price squeeze in those instances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from